Site Search
Site Search
Displaying results 581 - 590 of 601
7th edition - October 2011
Table of contents:
- Revised IMI Scientific Research Agenda released
- IMI 4th Call – initial statistics
- IMI forges links with the European Parliament
- IMI makes its mark in Krakow
- Major US report to Barack Obama mentions IMI
- New IMI project achievements booklet available now
- IMI presentations at forthcoming conferences
- News from the projects
6th edition - September 2011
Table of contents:
- Join IMI for a special event in Krakow, Poland
- Innovation in Action - IMI to highlight successes at European Parliament
- IMI 4th Call – Q&As published
- Watch IMI leaders on TV
- IMI States Representatives Group elects new chair
- New on the IMI website
- IMI presentations at forthcoming conferences
- News from the projects
IMI at the European Parliament
In a 'more-than-filled' conference room in the European Parliament in Brussels, IMI presented its achievements on Thursday 6 October 2011. The session, which was kindly hosted by Mr Mario Mauro, MEP, highlighted the impressive achievements of IMI projects. In the presentations ...
IMI – New opportunities for drug research in Europe
Over 50 people attended IMI’s half-day conference in Krakow, Poland, entitled ‘IMI – New opportunities for drug research in Europe’ on 12 October. The event was a session of the Congress of Polish Biotechnology and the Central European Congress of Life Sciences ( Eurobiotech ) ...
IMI 4th Call topic webinars
IMI held webinars on all seven of the 4th Call topics between 21 and 30 June 2011 inclusive. The webinars attracted between 25 and 45 participants and featured presentations of the Call topic as well as opportunities to ask questions via the chat function or over the phone ...
4th Edition - May 2011
Table of contents:
Open Info Day: 4th Call for proposals
IMI held its Open Info Day on its 4th Call for proposals at the Husa President Park Hotel in Brussels, Belgium on Friday 17 June 2011. Over 200 participants attended, representing all types of organisations including SMEs, academic and industry research, patient organisations and ...